Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 11:56 PM
Study NCT ID:
NCT01414894
Status:
COMPLETED
Last Update Posted:
2013-06-20
First Post:
2010-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage
Sponsor:
University of Washington
Organization:
Study Overview
Official Title:
Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPROVES
Brief Summary:
The purpose of our study is to determine how well Triple-H works and how safe it is. The investigators are hoping to determine the effects of starting the therapy early and to explore if hypervolemia and/or hypertension are beneficial, and what the optimal target ranges are.
Detailed Description:
Efficacy of Triple-H therapy.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: